Timothée Olivier/X
Dec 16, 2024, 13:18
Timothée Olivier: Randomized vs Real – World Evidence on the efficacy and toxicity of checkpoint inhibitors
Timothée Olivier shared a post on X:
” ‘RANDOMIZED versus REAL-WORLD EVIDENCE on the efficacy and toxicity of checkpoint inhibitors’
Equals the talk I gave at ESMO Immuno24 recorded live during one of our VKPrasad lab meeting followed by engaging Question and Answer session!
Also available on ‘DrugDevLetter’!
For more information click here.”
Timothée Olivier is a medical oncologist at the Oncology Division of Geneva University Hospital in Switzerland. He also serves as a visiting researcher at the University of California, San Francisco. His research focuses on meta-research, evidence-based medicine, health policy, drug regulation, quality of life, medical education, and screening.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 16, 2024, 13:11
Dec 16, 2024, 13:09
Dec 16, 2024, 13:01
Dec 16, 2024, 12:56
Dec 16, 2024, 12:23
Dec 16, 2024, 11:45